Nasdaq
$2.12▲ 0.71%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $147.5MShares out 69.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
11- 8.25Overnight26.08.25 09:03SCHEDULE 13D/AOwnership#●●●#●●●
Neuronetics, Inc.Bullish
The reporting person purchased 14,000 shares of Neuronetics, Inc. common stock on August 14, 2026, at a weighted average price of $3.16 per share. These shares were acquired in multiple transactions ranging from $3.13 to $3.17, and the reporting person will provide full transaction details upon request.…more
$2.12+0.71%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 8.19Regular26.08.20 03:13144Ownership
Neuronetics, Inc.
Neuronetics, Inc. insider MACAN WILLIAM ANDREW has filed an SEC Form 144 to report a proposed sale of company securities. This filing indicates an upcoming divestment of shares by a member of the management team.…more
$2.12+0.71%vs prev closeView filingShare - 8.18After-hours26.08.19 05:46144Ownership
Neuronetics, Inc.
Neuronetics, Inc. insider Macan William Andrew filed an SEC Form 144 on August 18, 2026, to report the proposed sale of company shares. This filing formally discloses the insider's intention to sell their holdings in the open market.…more
$2.12+0.71%vs prev closeView filingShare
10 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 3d agoPre-market26.10.21 21:30#●●●#●●●
Neuronetics Announces Q3 2026 Earnings Release Date
Neuronetics plans to release its third quarter 2026 financial and operating results before the market opens on November 4, 2026. The company will host a conference call on the same day to discuss the results.…more
$2.12+0.71%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.8Pre-market26.09.08 21:32
●●●●●●●● ●●●●● ●●●●●●
Neuronetics announced a first-of-its-kind integration between its TrakStar TMS platform and the AdvancedMD EHR system. This collaboration aims to streamline clinical and administrative workflows, reducing operational burdens for mental health practitioners.…more
$2.12+0.71%vs prev close - 8.11Pre-market26.08.11 20:50
●●●●●●●● ●●●●● ●●●●●●
뉴로네틱스는 2분기 매출이 전년 동기 대비 9.1% 성장하고 영업손실 폭을 크게 줄이며 수익성 개선 흐름을 보였습니다. 경영진 교체와 함께 연간 매출 가이던스를 조정하며 지속 가능한 성장을 위한 운영 효율화에 집중하고 있습니다.…more
$2.12+0.71%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report